The interference of atypical creatine kinase (CK; EC 2.7.3.2) with anion-exchange methods for the measurement of the CK-MB isoenzyme is now firmly established. False-positive results from this source are much more common than interferences caused by the BB isoenzyme. Atypical CK, at least in some patients, does not appear to be a genetic variant, nor could we relate it to a specific clinical diagnosis, to hypoxia, or to administration of a particular drug. Its behavior in an immuno-inhibition test for CK-B subunit indicates an Immunological difference from the normal M subunit. Thus the change in immunological properties is associated with the altered electrophoretic properties. The variability of electrophoretic patterns suggests that atypical CK may represent multiple forms of creatine kinase rather than a unique entity.
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Separation of CK isoenzymes on DEAE-Sephadex3
( 1) shows an increase in the presumed MB fraction, sustained in the serum of certain patients who have not suffered recent myocardial infarction (2, 3) . We termed this fraction "atypical creatine kinase" (CK-AT) because its electrophoretic mobility is intermediate between MM and MB (2) . Its presence has been confirmed by other investigators (4) (5) (6) (7) . In this report, we estimate the prevalence of factitious MB values resulting from interference by CK-AT and describe some additional properties of CK-AT.
Materials and Methods
Our original report (2) covered the period of April 9 to July 29, 1975 . The present study extends that period through May 2, 1978. Until January 3, 1977, our procedures for measurement of total CK activity, separation of CK-MB activity by ion-exchange column chromatography, and electrophoresis of CK isoenzymes on cellulose acetate were as originally described (2) . At that time, we made two changes: we routinely began using Roche CPK Reagent (Roche Diagnostics, Nutley, NJ 07110) for measurement of total CK in serum and CK-MB in column eluates and the Roche CPK-CS adaptation of
Mercer's technique. The latter change resulted in a slight
Patients are classified as "suspected atypicals" if three or more results for CK-MB by column are increased during at least one week. These become "confirmed atypicals" when one or more electrophoretograins demonstrate the presence of an atypical band.
Dade CK-Isoenzyme Marker (Dade Div., American Hospital Supply Corp., Miami, FL 33152) was used as a control in electrophoresis and in an experiment in which pooled fresh human serum was fractionated by column (Roche CPK-CS procedure), and the medium salt fraction was separated by electrophoresis after concentration. (12) . Unlike the rapid immuno-inhibition procedure, the immunoprecipitation method requires overnight incubation of serum and antibody mixtures followed by determination of the residual CK activity in the supernatant fluid after centrifugation of the mixtures.
In an experiment designed to see the extent to which CK-AT could be separated from CK-MB in the column method, three specimens were selected: serum from a confirmed CK-AT subject (patient V.P.), serum from a myocardial infarct patient near the peak MB value (patient F.A.), and the Dade CK Marker. Each was run six times by the Roche CPK.CS column method, modified by increasing the NaC1 concentration of the "low salt buffer" from 0.10 mol/L to 0.15 mol/L in 0.01 mol/L increments. Low and medium salt eluates were analyzed for CK activity. Aliquots of those eluates of patient V.P. were concentrated 10-fold in an Amicon concentrator and analyzed by electrophoresis and by the inhibition method. 
Results and Discussion
Review of Data on Patients
Some idea of the incidence of CK-AT may be gainedby inspection of It is apparent that the frequent appearance of CK-AT calls for awareness, both on the part of the clinical chemist who is using ion-exchange methods to separate CK isoenzymes and on the part of the clinician interpreting such test results. As will be shown later, similar awareness by those who use the immuno-inhibition method is also required.
We examined themedical charts of the 62 confirmed cases showing CK-AT, seeking some common denominator. The most frequent diagnostic categories cited upon final discharge areshown inTable 2. It is not surprising that heart disease of long standing was present in many patients, because 64% of the specimens analyzed came from the intensive care, coronary care, and progressive care units. However, the presence of CK-AT was confirmed in many patients not suffering from chronic heart disease. Thus the presence of CK-AT does not appear to be associated with a particular clinical diagnosis, a finding that is in agreement with those of others (4, 5, 7). Patients' records were checked for medications being received at the time of sampling. No drug was common to all CK-AT patients. Digoxin, the most commonly prescribed drug, was being administered to 63% of this series of patients. A sizable proportion (23%) had received no drug within 24 h 
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of venipuncture.
This would appear to rule out binding of a drug or drug metabolite to one of the threecommon isoenzymes ofCK, resulting in a change in effective charge, as an explanation for anomalous behavior on electrophoresis or ion-exchange columns.
The 62 patients in the confirmed atypical group were 19 men and 43 women. The men ranged in age from 48 to 87 (mean age, 65.7 years). The women ranged in age from 33 to 94, with a mean age of 67.3 years.
In our earlier publication (2), we noted the persistence of CK-AT, measured as apparent CK-MB by column chromatography in 14 patients.
In two patients undergoing coronary-bypass surgery, CK-AT was seen to decrease considerably after such surgery, but in neither case did the apparent CK-MB return to normal.
We have examined our expanded series of patients in search of unusual trends in serial determinations.
Illustrative cases are summarized in Table 3 . Patient V.P. showed no CK-MB, only CK-MM and CK-AT on electrophoresis.
Her CK-AT value is quite constant over a 1.5-year period; the longest time span during which the presence of CK-AT was followed in any patient in our earlier study was nine weeks. Patient A.L., with electrophoretic findings similar to those for patient V.P., showed CK-AT during a period spanning 13 months and three hospital admissions. The considerably higher apparent CK-MB seen during the most recent admission was not associated with any notable change in the clinical state.
Patient C.B., again with similar electrophoretic findings during a 1976 admission, was admitted moribund in 1978. Despite the dramatic deterioration in her physical state, results for total and CK-MB on admission were normal; subsequent CK-MB results were not suggestive of increases in either true CK-MB or C K-AT. This case is illustrative because it shows that (a) column-chromatographic increases in ap- Perhaps the most significant result of this retrospective studyisan awarenessthatCK-AT valuescan increase ordecline. Although we have not confirmed an increase and sub- patients, all three of whom had chronic heart disease, was revealing. Lim (8) reported two "sub-bands" observed in CK electrophoretograms of human sera, one type occurring between MM and MB, the other between MB and BB. We agree with his observation that the former type occurs much more frequently than the latter, but our patients do not fit his observation that the latter type is seen only in patients with neurological disorders and the former only in those suffering severe angina pectoris.
In fact, we observe thatCK-AT bands lying between MM and MB comprise a variety of sub-types. Most are found somewhat closer to MM than to MB, but are clearly resolvable. However, some, which appear as slight broadenings of MM, are difficult to detect. Some CK-AT bands are relatively sharp, others much more diffuse. Electrophoretograms of different subtypes retain their characteristic appearance in repeated runs. Ljungdahl and Gerhardt (7) also observed several subtypes of CK-AT lying between MM and MB. We next examined the behavior of CK-AT-containing sera in the Cardiozyme CK-MB immuno-inhibition test system. Results are shown in Table 4 . All were falsely positive for MB by the column method and all but one by the immuno-inhibition method. Results of testing sera containing CK-AT with the precipitating antibodies are seen in In their system, CK-MM was completely inhibited, CK-MB partly inhibited, and CK-AT not inhibited. Those authors concluded that CK-AT is not aberrant CK-MM, but is probably an abnormally migrating CK-BB. We have made several observations that are difficult to reconcile with their interpretation. We have observed a large number of electrophoretograms of sera with a very high proportion of CK-AT. In many of these, the MM band is very faint or even undetectable. In a patient with increasing CK-AT, we had the opportunity to perform serial assays by column and electrophoresis.
As the CK-AT band increased in intensity, the CK-MM band decreased, and could no longer be seen in the last pattern run. 
10).
We previously have shown that CK-AT in one serum specimen was eluted from an uncharged Sephadex column at the same time as CK-MM or CK-MB, which argues against macromolecular binding (2) . However, several observations suggest that binding of one of the usual isoenzymes to another substance, small or large, may account for the formation of CK-AT. Partial dissociation of such a complex during electrophoresis might account for the multiplicity of patterns illustrated in Figure 1 . Moreover, staining of the CK-AT band is far more intense than that of MM, MB, or BB, again suggesting removal of a binding substance that inhibits activity in the total CK assay system. We sought evidence of lipid binding by incubating serum containing C K-AT with a nonionic detergent (Triton X-100; Rohm and Haas Co., Philadelphia, PA 19105) as described by Epstein et al. (11) . Subsequent electrophoresis showed no change of the CK-AT band. Other attempts to alter the electrophoretic mobility of the CK isoenzyme were unsuccessful. Jacobs et al. (13) suggested that a change in mobility might be caused by formation of a mixed disulfide on one of the polypeptide chains of the dimeric CK molecule. We were unable to affect the mobility of the MM isoenzyme by adding L-cystine to normal sera. Neuraminidase (EC 3.2.1.18) added to a serum containing We therefore examined patients with moderate to severe hypoxia for the presence of CK-AT; the results are summarized in Table 6 . The first two of these patients showed borderline increases in apparent CK-MB by DEAE-Sephadex column chromatography. All subsequent patients were normal by this procedure. Electrophoresis and the immuno-inhibition assay system provided no evidence for the presence of CK-AT in these eight patients with hypoxemia. These data therefore provide no support for Lim's postulated mechanism.
Finally, we explored the possibility of reducing the incidence of false positives in the column method by increasing the concentration of NaCl in the low salt buffer sufficiently to remove both CK-MM and CK-AT without eluting CK-MB (see Materials and Methods), but we couldnot effectively separate CK-AT without inordinate lossof CK-MB. However, Clejan (14) reports successwith a similar approach.
A reviewer of this paper noted the presence of atypical activity in control specimens sent by the Center for Disease Control in a recent CK survey. Behavior on ion-exchange columns (Mercer method) and with use of the Cardiozyme immuno-inhibition method was similar to that described in our study.
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